We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02399566
Recruitment Status : Unknown
Verified March 2015 by Jianhua Chen, Hunan Province Tumor Hospital.
Recruitment status was:  Not yet recruiting
First Posted : March 26, 2015
Last Update Posted : March 26, 2015
Information provided by (Responsible Party):
Jianhua Chen, Hunan Province Tumor Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : January 2018
Estimated Study Completion Date : January 2019